Invention Publication
- Patent Title: CD38-NAD+ REGULATED METABOLIC AXIS IN ANTI-TUMOR IMMUNOTHERAPY
-
Application No.: US18543191Application Date: 2023-12-18
-
Publication No.: US20240122986A1Publication Date: 2024-04-18
- Inventor: Shikhar MEHROTRA , Shilpak CHATTERJEE
- Applicant: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
- Applicant Address: US SC Charleston
- Assignee: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
- Current Assignee: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
- Current Assignee Address: US SC Charleston
- Main IPC: A61K35/17
- IPC: A61K35/17 ; A61K9/00 ; A61K35/26 ; A61K39/395 ; A61K45/06 ; A61P35/00 ; C07K16/24 ; C07K16/28 ; C07K16/30 ; C12N5/0783
Abstract:
The present disclosure provides methods of producing hybrid Th1/Th17 cells. Also provided herein are methods of treating cancer comprising targeting the CD38-mediated metabolic axis.
Information query
IPC分类:
